nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenidol—Difenoxin—OPRM1—nicotine dependence	0.0992	0.16	CrCbGaD
Diphenidol—Levomethadyl Acetate—CHRNB4—nicotine dependence	0.0893	0.144	CrCbGaD
Diphenidol—Methadyl Acetate—OPRM1—nicotine dependence	0.0809	0.131	CrCbGaD
Diphenidol—Methadone—CHRNA10—nicotine dependence	0.0729	0.118	CrCbGaD
Diphenidol—Diphenoxylate—OPRM1—nicotine dependence	0.0699	0.113	CrCbGaD
Diphenidol—Levomethadyl Acetate—CHRNA3—nicotine dependence	0.0619	0.0999	CrCbGaD
Diphenidol—Levomethadyl Acetate—OPRM1—nicotine dependence	0.0352	0.0568	CrCbGaD
Diphenidol—Dextropropoxyphene—OPRM1—nicotine dependence	0.0304	0.0491	CrCbGaD
Diphenidol—Fentanyl—OPRM1—nicotine dependence	0.0301	0.0486	CrCbGaD
Diphenidol—Loperamide—OPRM1—nicotine dependence	0.029	0.0468	CrCbGaD
Diphenidol—Methadone—OPRM1—nicotine dependence	0.0206	0.0333	CrCbGaD
Diphenidol—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.0163	0.0429	CbGpPWpGaD
Diphenidol—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.0163	0.0428	CbGpPWpGaD
Diphenidol—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.0161	0.0424	CbGpPWpGaD
Diphenidol—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0137	0.0361	CbGpPWpGaD
Diphenidol—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0137	0.036	CbGpPWpGaD
Diphenidol—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0136	0.0356	CbGpPWpGaD
Diphenidol—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0126	0.0331	CbGpPWpGaD
Diphenidol—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0126	0.033	CbGpPWpGaD
Diphenidol—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0124	0.0327	CbGpPWpGaD
Diphenidol—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.011	0.0289	CbGpPWpGaD
Diphenidol—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00943	0.0248	CbGpPWpGaD
Diphenidol—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00784	0.0206	CbGpPWpGaD
Diphenidol—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00781	0.0205	CbGpPWpGaD
Diphenidol—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00774	0.0203	CbGpPWpGaD
Diphenidol—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00751	0.0197	CbGpPWpGaD
Diphenidol—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00749	0.0197	CbGpPWpGaD
Diphenidol—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00742	0.0195	CbGpPWpGaD
Diphenidol—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00675	0.0177	CbGpPWpGaD
Diphenidol—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00673	0.0177	CbGpPWpGaD
Diphenidol—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00666	0.0175	CbGpPWpGaD
Diphenidol—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0063	0.0165	CbGpPWpGaD
Diphenidol—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00572	0.015	CbGpPWpGaD
Diphenidol—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00521	0.0137	CbGpPWpGaD
Diphenidol—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00464	0.0122	CbGpPWpGaD
Diphenidol—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00436	0.0115	CbGpPWpGaD
Diphenidol—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00435	0.0114	CbGpPWpGaD
Diphenidol—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0043	0.0113	CbGpPWpGaD
Diphenidol—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.00385	0.0101	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00381	0.01	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0038	0.00999	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00376	0.0099	CbGpPWpGaD
Diphenidol—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00374	0.00982	CbGpPWpGaD
Diphenidol—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00372	0.00979	CbGpPWpGaD
Diphenidol—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00369	0.00969	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00346	0.0091	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00345	0.00907	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00342	0.00899	CbGpPWpGaD
Diphenidol—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00335	0.00881	CbGpPWpGaD
Diphenidol—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00315	0.00829	CbGpPWpGaD
Diphenidol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00314	0.00826	CbGpPWpGaD
Diphenidol—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00311	0.00818	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.00299	0.00787	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.00298	0.00784	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.00295	0.00776	CbGpPWpGaD
Diphenidol—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.00285	0.00748	CbGpPWpGaD
Diphenidol—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.00284	0.00745	CbGpPWpGaD
Diphenidol—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.00281	0.00738	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.00272	0.00714	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.00271	0.00712	CbGpPWpGaD
Diphenidol—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0027	0.0071	CbGpPWpGaD
Diphenidol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00269	0.00708	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.00268	0.00705	CbGpPWpGaD
Diphenidol—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00267	0.00701	CbGpPWpGaD
Diphenidol—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.00206	0.00541	CbGpPWpGaD
Diphenidol—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.00205	0.00539	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.00205	0.00538	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.00204	0.00536	CbGpPWpGaD
Diphenidol—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.00203	0.00534	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.00202	0.00531	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00161	0.00423	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.00161	0.00422	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	0.0016	0.00421	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FGD1—nicotine dependence	0.0016	0.00421	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00159	0.00417	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.00158	0.00417	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CYP2A7—nicotine dependence	0.00157	0.00413	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.00146	0.00384	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	0.00146	0.00383	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.00144	0.00379	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.00142	0.00373	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	0.00141	0.00372	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.0014	0.00368	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.00116	0.00306	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	0.00116	0.00305	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.00115	0.00302	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.00106	0.00277	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	0.00105	0.00277	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.00104	0.00274	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.000999	0.00263	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—WASF2—nicotine dependence	0.000996	0.00262	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000986	0.00259	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.000958	0.00252	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—WASF1—nicotine dependence	0.000955	0.00251	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000946	0.00249	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000863	0.00227	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	0.00086	0.00226	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000851	0.00224	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—DRD2—nicotine dependence	0.000624	0.00164	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—DRD2—nicotine dependence	0.000622	0.00163	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000616	0.00162	CbGpPWpGaD
